eSubmission: Updates of 'Validation Criteria'
Recommendation
Wednesday, 21 May 2025 10.00 - 16.00 h
How to use and prepare an MA with a CEP 2.0
Register now for ECA's GMP Newsletter
For medicinal products for human use, the so-called 'electronic Common Technical Document (eCTD)' is used as the standard for dossier submissions. It consists of five modules (modules 1-5). In the middle of the year, a number of updates were published for this, as you could already read under EMA: Update of Module 1. Now, further updates have been published on the EMA's eSubmission website.
Validation criteria
The list of 'Validation Criteria' has been updated so that it is now available in version 8.1. The 'Release notes for version 8.1 of the EU eCTD M1 Validation Criteria (minor correction)' list the new features of the document in the usual manner and emphasise the differences compared to the previous version 8.0. The introduction and transition periods for use have been set for 01 December 2024 for versions v7.1, 8.0 or v8.1. From 01 March 2025, version 8.1 of the 'Validation Criteria' is mandatory.
The information of the updated passages can be found here.
Related GMP News
16.04.2025EMA: Revised IRIS Documents
09.04.2025Centralised Procedures: Q&As Updated
12.03.2025CMDh/HMA: Guidance Documents on Variation Notifications Updated
11.03.2025EMA: Renewal of Q&A Document for "Centralized Procedures"
11.03.2025Centralised Procedures: Q&A Documents also Updated for Biosimilars
29.01.2025CMDh/HMA: Updated Guidance Documents on Variation Notifications